What is Safinamide?

Category: Prescription Drugs

Most popular types: Xadago

false

Safinamide is an anti-Parkinson's agent and MAO inhibitor which can enhance the activity of dopamine. It is typically used as an add on treatment for existing therapy with levodopa/carbidopa.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 2
None 4

Commonly reported side effects and conditions associated with Safinamide

Side effect Patients
Balance problems 1

Dosages

Based on patients currently taking Safinamide

Dosage Patients
100 mg daily 3
50 mg daily 1

Why patients stopped taking Safinamide

Multiple reasons could be selected

Reason Patients
Change in health plan coverage 1
Expense 1
Side effects too severe 1
See all 2 patients who've stopped taking Safinamide

Duration

Currently taking Safinamide

Duration Patients
1 - 6 months 1
6 months - 1 year 1
2 - 5 years 2

Stopped taking Safinamide

Duration Patients
Less than 1 month 1
6 months - 1 year 1
Adherence
Adherence Evaluations
Always 6
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 6
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 2
Not specified 4

What people switch to and from

Patients started taking Safinamide after stopping:

Treatment Patients
Rasagiline (Azilect) 2

Patients stopped taking Safinamide and switched to:

Treatment Patients
Ropinirole (Requip) 1
Last updated:

1 patient evaluation for Safinamide

Mar 25, 2018 (Started Jan 26, 2018)

  • Effectiveness
    Major (for Parkinson's disease)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 50 mg Daily
Advice & Tips: smooth out symptoms all day long. Off times are briefer and not as bad. Sometimes I go several days in a row without symptoms except at night when I take less levadopa.

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Safinamide